Sartorius Ag (NASDAQ:SARTF) Downgraded by Zacks Investment Research to “Sell”

Sartorius Ag (NASDAQ:SARTF) was downgraded by Zacks Investment Research from a “hold” rating to a “sell” rating in a research report issued on Wednesday, October 11th.

According to Zacks, “Sartorius AG is a pharmaceutical and laboratory equipment supplier. The company manufactures equipment for biomolecular and microbial separations, cell culture, concentration, fermentation and purification. Sartorius AG is headquartered in Goettingen, Germany. “

Separately, DZ Bank AG restated a “sell” rating on shares of Sartorius Ag in a research note on Friday, July 21st.

Sartorius Ag (NASDAQ:SARTF) remained flat at $89.00 during trading on Wednesday. The firm has a market cap of $6.09 billion and a P/E ratio of 49.20. Sartorius Ag has a 52 week low of $75.00 and a 52 week high of $96.00.

COPYRIGHT VIOLATION NOTICE: “Sartorius Ag (NASDAQ:SARTF) Downgraded by Zacks Investment Research to “Sell”” was posted by The Ledger Gazette and is the sole property of of The Ledger Gazette. If you are accessing this story on another publication, it was illegally copied and reposted in violation of U.S. and international copyright and trademark legislation. The legal version of this story can be read at https://ledgergazette.com/2017/10/20/sartorius-ag-sartf-downgraded-to-sell-at-zacks-investment-research.html.

Get a free copy of the Zacks research report on Sartorius Ag (SARTF)

For more

According to Zacks, “Sartorius AG is a pharmaceutical and laboratory equipment supplier. The company manufactures equipment for biomolecular and microbial separations, cell culture, concentration, fermentation and purification. Sartorius AG is headquartered in Goettingen, Germany. “

Separately, DZ Bank AG restated a “sell” rating on shares of Sartorius Ag in a research note on Friday, July 21st.

Sartorius Ag (NASDAQ:SARTF) remained flat at $89.00 during trading on Wednesday. The firm has a market cap of $6.09 billion and a P/E ratio of 49.20. Sartorius Ag has a 52 week low of $75.00 and a 52 week high of $96.00.

COPYRIGHT VIOLATION NOTICE: “Sartorius Ag (NASDAQ:SARTF) Downgraded by Zacks Investment Research to “Sell”” was posted by The Ledger Gazette and is the sole property of of The Ledger Gazette. If you are accessing this story on another publication, it was illegally copied and reposted in violation of U.S. and international copyright and trademark legislation. The legal version of this story can be read at https://ledgergazette.com/2017/10/20/sartorius-ag-sartf-downgraded-to-sell-at-zacks-investment-research.html.

Get a free copy of the Zacks research report on Sartorius Ag (SARTF)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Receive News & Ratings for Sartorius Ag Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Sartorius Ag and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply